Robert Andrade - Dec 20, 2021 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Chief Financial Officer
Signature
/s/ Robert Andrade, Chief Financial Officer
Stock symbol
FENC
Transactions as of
Dec 20, 2021
Transactions value $
$0
Form type
4
Date filed
12/20/2021, 04:48 PM
Previous filing
Jun 3, 2021
Next filing
Sep 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option (right to buy) Award $0 +75K $0.00 75K Dec 20, 2021 Common Shares 75K $4.08 Direct F1, F3
transaction FENC Restricted Share Unit (right to receive value of a share) Award $0 +37.5K $0.00 37.5K Dec 20, 2021 Common Shares 37.5K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 20, 2021, Robert Andrade was granted an incentive stock option to purchase 75,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F2 On December 20, 2021, Robert Andrade was granted restricted share units to receive 37,500 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F3 Item vests 100% upon FDA approval of PEDMARKTM.